Triacin-c label

Triacin-c

Triacin-c Recall

Get an alert when a recall is issued.

Side Effects & Adverse Reactions

Triprolidine and pseudoephedrine hydrochlorides and codeine phosphate syrup should be used with considerable caution in patients with increased intraocular pressure (narrow angle glaucoma), stenosing peptic ulcer, pyloroduodenal obstruction, symptomatic prostatic hypertrophy, bladder neck obstruction, hypertension, diabetes mellitus, ischemic heart disease, and hyperthyroidism.

In the presence of head injury or other intracranial lesions, the respiratory depressant effects of codeine and other narcotics may be markedly enhanced, as well as their capacity for elevating cerebrospinal fluid pressure.

Narcotics also produce other CNS depressant effects, such as drowsiness, that may further obscure the clinical course of patients with head injuries.

Codeine or other narcotics may obscure signs on which to judge the diagnosis or clinical course of patients with acute abdominal conditions.

FDA Safety Alerts

There are currently no FDA safety alerts available for this drug.

Manufacturer Warnings

There is currently no manufacturer warning information available for this drug.

FDA Labeling Changes

There are currently no FDA labeling changes available for this drug.

Uses

Triprolidine and pseudoephedrine hydrochlorides and codeine phosphate syrup is indicated for temporary relief of coughs and upper respiratory symptoms, including nasal congestion, associated with allergy or the common cold.

History

There is currently no drug history available for this drug.

Other Information

Each 5 mL (one teaspoonful) of syrup for oral administration contains:

Codeine Phosphate……10 mg

WARNING: May be habit forming.
Triprolidine Hydrochloride……1.25 mg
Pseudoephedrine Hydrochloride……30 mg

Alcohol 4.3%. Added as preservatives: Sodium Benzoate 0.1%, Methylparaben 0.15%.

Triprolidine and pseudoephedrine hydrochlorides and codeine phosphate syrup produces antitussive, antihistaminic and nasal decongestant effects. The components have the following chemical names and structural formulas:

Codeine Phosphate, USP

[IC]7,8-didehydro-4,5 α-epoxy-3-methoxy-17-methylmorphinan-6α-ol phosphate (1:1) (salt) hemihydrate[/IC]

Image from Drug Label Content

Triprolidine Hydrochloride, USP

[IC](E)-2-[3(1-Pyrrolidinyl)-1-p-tolylpropenyl]pyridine monohydrochloride monohydrate[/IC]

Image from Drug Label Content

Pseudoephedrine Hydrochloride, USP

[IC]Benzenemethanol, α-[1-(methylamino)ethyl]-,[S-(R*, R*)]- hydrochloride[/IC]

Image from Drug Label Content

Triacin-c Manufacturers

  • Triacin-c | Actavis Mid Atlantic Llc
    No Recall

    Triacin-c | Actavis Mid Atlantic Llc

    Triacin-c | Actavis Mid Atlantic Llc

    DOSAGE SHOULD BE INDIVIDUALIZED ACCORDING TO THE NEEDS AND RESPONSE OF THE PATIENT.

    Usual Dose: Teaspoonfuls (5 mL) Adults and children 12 years and older 2 teaspoonfuls (10 mL) every 4 to 6 hours, not to exceed 8 teaspoonfuls (40 mL) in 24 hours. Children 6 to under 12 years 1 teaspoonful (5 mL) every 4 to 6 hours, not to exceed 4 teaspoonfuls (20 mL) in 24 hours. Children 2 to under 6 years ½ teaspoonful (2.5 mL) every 4 to 6 hours, not to exceed 2 teaspoonfuls
  • Sti Pharma Llc
    Triacin-c | Sti Pharma Llc
    No Recall

    Triacin-c | Sti Pharma Llc

    Triacin-c | Sti Pharma Llc

    DOSAGE SHOULD BE INDIVIDUALIZED ACCORDING TO THE NEEDS AND RESPONSE OF THE PATIENT.

    Usual Dose:

    Teaspoonfuls (5 mL)

    Adults and children 12 years and older

    2 teaspoonfuls (10 mL) every 4 to 6 hours, not to exceed 8 teaspoonfuls (40 mL) in 24 hours.

    Children 6 to under 12 years

    1 teaspoonful (5 mL) every 4 to 6 hours, not to exceed 4 teaspoonfuls (20 mL) in 24 hours.

    Children 2 to under 6 years

    ½ teaspoonful (2.5 mL) every 4 to 6 hours, not to exceed 2 teaspoonfuls